ASTCT

Influence. Innovate. Growth. ASTCT President Margaret MacMillan, MD, MSc, FRCPC and Past President David Porter, MD, discuss the future of ASTCT and the priorities shaping our 2026–2028 Strategic Plan. Watch to learn more: youtube.com/watch?v=yFvlNP…

ASTCT's New Investigator Awards (NIAs) are designed to encourage clinical and/or laboratory research by young investigators in the field of hematopoietic cell, cell therapy and/or gene therapy. Awardees will receive $50,000 per year for a total of two years, starting July 1, 2027, to assist with research costs and/or salary. Apply now or share this opportunity: ow.ly/1ngh50WuV9P

Mark your calendars! ASTCT has several upcoming events designed to support connection, education and advancement in transplantation and cellular therapy. Explore what’s ahead and find additional opportunities to engage with the ASTCT community by viewing the full meetings calendar: astct.org/attend

Take some time this weekend to explore the @ASTCT_Journal cord blood journal collection, updated for National Cord Blood Awareness Month. View the collection: astctjournal.org/cord-blood-awa…

The #Tandem27 APP Track is seeking speakers for the 2027 meetings in Orlando! The planing committee is especially seeking proposals that are evidence-based, highlight current data, and illustrate advances in the field of transplantation and cellular therapy. Visit the link below to learn more and apply by Sunday, July 12. Apply now: ow.ly/Cpkq50ZieAC

ASCO 2026 highlights 🎧 New insights in myeloma, AML, lymphoma & CAR-T may reshape clinical practice—hear expert takeaways from this ASTCT X Spaces session with @CancerNetwork and ASTCT Talks: ow.ly/OMbz50ZlPto

Registration now open 📣 ASTCT, in collaboration with the Colorado Blood Cancer Institute (CBCI), is pleased to announce registration is now open for the inaugural Meeting on Transplant and Cellular Therapy for Immunological Disorders, taking place October 1-2, 2026, at the Gaylord Rockies Resort & Convention Center in Aurora, Colorado. View the program, housing details and registration rates: ow.ly/m4i850ZlPqJ

ASTCT's New Investigator Awards (NIAs) are designed to encourage clinical and/or laboratory research by young investigators in the field of hematopoietic cell, cell therapy and/or gene therapy. Awardees will receive $50,000 per year for a total of two years, starting July 1, 2027, to assist with research costs and/or salary. Apply now or share this opportunity: ow.ly/1ngh50WuV9P

Calling all APPs, nurses, fellows & in-training professionals! Gain a deeper understanding of diagnostic evaluations & treatments for acute & chronic complications of HSCT & cellular therapies at the virtual Clinical Education Conference. Register now: ow.ly/Nxgb50W7UU7

The #Tandem27 APP Track is seeking speakers for the 2027 meetings in Orlando! The planing committee is especially seeking proposals that are evidence-based, highlight current data, and illustrate advances in the field of transplantation and cellular therapy. Visit the link below to learn more and apply by Sunday, July 12. Apply now: ow.ly/Cpkq50ZieAC

The July issue of 'Transplantation and Cellular Therapy,' is now available online: astctjournal.org/current @ELShematology

New data show upfront systemic steroids in grade I acute GVHD may increase steroid-refractory disease and NRM—supporting a watch-and-wait approach. Read more: ow.ly/L5hH50Zg3xJ

Explore GI toxicities in CAR-T for lymphomas with insights from our co-branded podcasts—ASTCT Talks + Oncology On The Go. Tune in for expert perspectives on recognition & management: ow.ly/6pfL50Zg3t3

The #Tandem27 APP Track is seeking speakers for the 2027 meetings in Orlando! The planing committee is especially seeking proposals that are evidence-based, highlight current data, and illustrate advances in the field of transplantation and cellular therapy. Visit the link below to learn more and apply by Sunday, July 12. Apply now: ow.ly/Cpkq50ZieAC

Submit your interest to join an Association of Cancer Care Centers interactive virtual workshop on improving timely referral and care coordination for patients with metastatic melanoma who may be eligible to receive tumor-infiltrating lymphocyte (TIL) cell therapy. This multidisciplinary discussion will bring together cancer care professionals from authorized treatment centers (ATCs) and affiliated community practices. Attendance is limited and selected participants will receive a $250 honorarium. Submit interest through the links in the comments below.

Join ASTCT today and unlock member savings on the 2027 Tandem Meetings and other educational programs. Maximize your investment by joining during our extended membership period and maintain your benefits through 2027: ow.ly/6R7q50Zg3FX

Last call: Applications for the #Tandem27 Pharmacy Trackare due today! Topics for 2027 include grants, solid tumors, gene therapy, GVHD and more. Visit the link below to learn more and apply: ow.ly/Z3xe50ZbVPy

Take some time this weekend to explore the @ASTCT_Journal cord blood journal collection, updated for National Cord Blood Awareness Month. View the collection: astctjournal.org/cord-blood-awa…

🧑‍🔬Real-world TIL data in melanoma Lifileucel shows strong responses—but access challenges remain, with many patients unable to reach infusion. Early referral and streamlined workflows are key. Read more: ow.ly/8sng50Zg3v8

In the ASTCT Talks episode "Gene Therapy Today and Tomorrow," Dr. Nirali Shah is joined by Dr. Christy Duncan and Dr. Sung‑Yun Pai to talk through future outlook in the field, discussing where they may be in five years. Listen to the episode on Nucleus or on your favorite app: #nucleus_body_content" target="_blank" rel="nofollow noopener">astct.org/Nucleus/Articl…

In the ASTCT Talks episode "Gene Therapy Today and Tomorrow," Dr. Nirali Shah is joined by Dr. Christy Duncan and Dr. Sung‑Yun Pai to talk through future outlook in the field, discussing where they may be in five years. Listen to the episode on Nucleus or on your favorite app: #nucleus_body_content" target="_blank" rel="nofollow noopener">astct.org/Nucleus/Articl…